Free fatty acids, insulin resistance, and corrected QT intervals in morbid obesity: Effect of weight loss during 6 months with differing dietary interventions

Endocrine Practice

Volumn 11, Issue 4, 2005, Pages 234-239

  Seshadri, Prakash ^a   Samaha, Frederick F ^a,b   Stern, Linda ^b   Chicano, Kathryn L ^b   Daily, Denise A ^b   Iqbal, Nayyar ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; INSULIN;

ARTICLE; BLOOD; CARBOHYDRATE DIET; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; ELECTROCARDIOGRAPHY; FAT INTAKE; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; INSULIN RESISTANCE; LOW CALORY DIET; LOW CARBOHYDRATE DIET; LOW FAT DIET; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MORBID OBESITY; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

BLOOD GLUCOSE; DIET, CARBOHYDRATE-RESTRICTED; DIET, FAT-RESTRICTED; DIET, REDUCING; DIETARY CARBOHYDRATES; DIETARY FATS; ELECTROCARDIOGRAPHY; FATTY ACIDS, NONESTERIFIED; FEMALE; HEART RATE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY, MORBID; PATIENT COMPLIANCE;

EID: 33644678746     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.11.4.234     Document Type: Article

References (32)

1. Dekker JM, Feskens EJ, Schouten EG, Klootwijk P, Pool J, Kromhout D. QTc duration is associated with levels of insulin and glucose intolerance: the Zutphen Elderly Study. Diabetes. 1996;45:376-380.
2. Corbi GM, Carbone S, Ziccardi P, et al. FFAs and QT intervals in obese women with visceral adiposity: effects of sustained weight loss over 1 year. J Clin Endocrinol Metab. 2002;87:2080-2083.
3. Shimoni Y, Severson D, Ewart HS. Insulin resistance and the modulation of rat cardiac K+ currents. Am J Physiol Heart Circ Physiol. 2000;279:H639-H649.
4. Kim D, Duff RA. Regulation of K+ channels in cardiac myocytes by free fatty acids. Circ Res. 2001;67:1040-1046.
5. Boden G. Free fatty acids - the link between obesity and insulin resistance. Endocr Pract. 2001;7:44-51.
6. Samaha FF, Iqbal N, Seshadri P, et al. A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med. 2003;348:2074-2081.
7. Esposito K, Pontillo A, Di Palo C, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women. JAMA. 2003;289:1799-1804.
8. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report [erratum in Obes Res. 1998;6:464].
9. Obes Res. 1998;6(Suppl 2):51S-209S.
10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
11. Pavo I, Jermendy G, Varkonyi TT, et al. Effect of pioglitazone compared with metformin on glycemic control and indicators of insulin sensitivity in recently diagnosed patients with type 2 diabetes. J Clin Endocrinol Metab. 2003;88:1637-1645.
12. Dole VP, Meinertz H. Microdetermination of long-chain fatty acids in plasma and tissues. J Biol Chem. 1960;235: 2595-2599.
13. Jeevanandam M, Hsu YC, Ramias L, Schiller WR. A rapid, automated micromethod for measuring free fatty acids in plasma/serum. Clin Chem. 1989;35:2228-2231.
14. Puttmann M, Krug H, von Ochsenstein E, Kattermann R. Fast HPLC determination of serum free fatty acids in the picomole range. Clin Chem. 1993;39:825-832.
15. Bazzett HC. An analysis of the time relations of electrocardiograms. Heart. 1920;7:353-367.
16. Karvetti RL, Knuts LR. Validity of the 24-hour dietary recall. J Am Diet Assoc. 1985;85:1437-1442.
17. Al-Khatib SM, LaPointe NM, Kramer JM, Califf RM. What clinicians should know about the QT interval [erratum in JAMA. 2003;290:1318].
18. JAMA. 2003;289:2120-2127.
19. Festa A, D'Agostino R Jr, Rautaharju P, et al. Is QT interval a marker of subclinical atherosclerosis in nondiabetic subjects? The Insulin Resistance Atherosclerosis Study (IRAS). Stroke. 1999;30:1566-1571.
20. Zimetbaum P, Josephson ME. Risk factors for and diagnosis of the long QT syndromes and torsades de pointes. UpToDate. 2003. Available at: www.uptodate.com. Accessed for verification May 5, 2005.
21. el-Gamal A, Gallagher D, Nawras A, et al. Effects of obesity on QT, RR, and QTc intervals. Am J Cardiol. 1995; 75:956-959.
22. Peiris AN, Thakur RK, Sothmann MS, et al. Relationship of regional fat distribution and obesity to electrocardiographic parameters in healthy premenopausal women. South Med J. 1991;84:961-965.
23. Pietrobelli A, Rothacker D, Gallagher D, Heymsfield SB. Electrocardiographic QTc interval: short-term weight loss effects. Int J Obes Relat Metab Disord. 1997;21:110-114.
24. Zuckerman E, Yeshurun D, Goldhammer E, Shiran A. 24 h electrocardiographic monitoring in morbidly obese patients during short-term zero calorie diet. Int J Obes Relat Metab Disord. 1993;17:359-361.
25. Hale PJ, Singh BM, Crase J, Baddeley RM, Nattrass M. Following weight loss in massively obese patients correction of the insulin resistance of fat metabolism is delayed relative to the improvement in carbohydrate metabolism. Metabolism. 1988;37:411-417.
26. Blaak EE, Wolffenbuttel BH, Saris WH, Pelsers MM, Wagenmakers AJ. Weight reduction and the impaired plasma-derived free fatty acid oxidation in type 2 diabetic subjects. J Clin Endocrinol Metab. 2001;86:1638-1644.
27. McNulty PH. Insulin resistance and cardiac mass: the end of the beginning? Obes Res. 2003;11:507-508.
28. Iacobellis G, Ribaudo MC, Zappaterreno A, et al. Relationship of insulin sensitivity and left ventricular mass in uncomplicated obesity. Obes Res. 2003;11:518-524.
29. Oikarinen L, Nieminen MS, Toivonen L, et al (LIFE Study Investigators). Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention for Endpoint Reduction (LIFE) Study. Am Heart J. 2003;145:919-925.
30. Wirth A, Kroger H. Improvement of left ventricular morphology and function in obese subjects following a diet and exercise program. Int J Obes Relat Metab Disord. 1995; 19:61-66.
31. Robbins J, Nelson JC, Rautaharju PM, Gottdiener JS. The association between the length of the QT interval and mortality in the Cardiovascular Health Study. Am J Med. 2003;115:689-694.
32. Padmanabhan S, Silvet H, Amin J, Pai RG. Prognostic value of QT interval and QT dispersion in patients with left ventricular systolic dysfunction: results from a cohort of 2265 patients with an ejection fraction of < or =40%. Am Heart J. 2003;145:132-138.